Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
21
MBLY Quote, Financials, Valuation and Earnings
Last price:
$17.51
Seasonality move
:
-1.07%
Day range:
$16.91 - $18.36
52-week range:
$10.48 - $44.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.86x
P/B ratio:
1.18x
Volume:
6.3M
Avg. volume:
6.8M
1-year change:
-58.43%
Market cap:
$14.2B
Revenue:
$2.1B
EPS (TTM):
-$3.65
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $879M | $967M | $1.4B | $1.9B | $2.1B | |
| Revenue Growth (YoY) | -- | 10.01% | 43.33% | 34.85% | 11.24% | |
| Cost of Revenues | $456M | $591M | $731M | $947M | $1B | |
| Gross Profit | $423M | $376M | $655M | $922M | $1B | |
| Gross Profit Margin | 48.12% | 38.88% | 47.26% | 49.33% | 50.36% | |
| R&D Expenses | $384M | $440M | $544M | $789M | $889M | |
| Selling, General & Admin | $125M | $149M | $168M | $170M | $191M | |
| Other Inc / (Exp) | -$4M | -$5M | -- | -- | -- | |
| Operating Expenses | $509M | $589M | $712M | $959M | $1.1B | |
| Operating Income | -$86M | -$213M | -$57M | -$37M | -$33M | |
| Net Interest Expenses | $235M | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$325M | -$212M | -$57M | -$32M | $16M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3M | -$16M | $18M | $50M | $43M | |
| Net Income to Company | -$328M | -$196M | -$75M | -$82M | -$27M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$328M | -$196M | -$75M | -$82M | -$27M | |
| Basic EPS (Cont. Ops) | -$0.41 | -$0.25 | -$0.09 | -$0.11 | -$0.03 | |
| Diluted EPS (Cont. Ops) | -$0.41 | -$0.25 | -$0.09 | -$0.11 | -$0.03 | |
| Weighted Average Basic Share | $795.8M | $795.8M | $795.8M | $759M | $805M | |
| Weighted Average Diluted Share | $795.8M | $795.8M | $795.8M | $759M | $805M | |
| EBITDA | $252M | $251M | $469M | $559M | $529M | |
| EBIT | -$86M | -$212M | -$57M | -$8M | $16M | |
| Revenue (Reported) | $879M | $967M | $1.4B | $1.9B | $2.1B | |
| Operating Income (Reported) | -$86M | -$213M | -$57M | -$37M | -$33M | |
| Operating Income (Adjusted) | -$86M | -$212M | -$57M | -$8M | $16M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $326M | $450M | $530M | $486M | |
| Revenue Growth (YoY) | -- | -- | 38.04% | 17.78% | -8.3% | |
| Cost of Revenues | -- | $173M | $233M | $258M | $249M | |
| Gross Profit | -- | $153M | $217M | $272M | $237M | |
| Gross Profit Margin | -- | 46.93% | 48.22% | 51.32% | 48.77% | |
| R&D Expenses | -- | $132M | $206M | $218M | $303M | |
| Selling, General & Admin | -- | $41M | $36M | $46M | $46M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -$2.7B | |
| Operating Expenses | -- | $173M | $242M | $264M | $349M | |
| Operating Income | -- | -$20M | -$25M | $8M | -$112M | |
| Net Interest Expenses | -- | -- | $5M | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$20M | -$30M | $23M | -$2.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $6M | $15M | $6M | -$78M | |
| Net Income to Company | -- | -- | -$45M | $17M | -$2.7B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$26M | -$45M | $17M | -$2.7B | |
| Basic EPS (Cont. Ops) | -- | -$0.03 | -$0.06 | $0.02 | -$3.35 | |
| Diluted EPS (Cont. Ops) | -- | -$0.03 | -$0.06 | $0.02 | -$3.35 | |
| Weighted Average Basic Share | -- | $795.8M | $796.3M | $806M | $811M | |
| Weighted Average Diluted Share | -- | $795.8M | $796.3M | $810M | $811M | |
| EBITDA | -- | $108M | $119M | $128M | $15M | |
| EBIT | -- | -$20M | -$19M | $8M | -$112M | |
| Revenue (Reported) | -- | $326M | $450M | $530M | $486M | |
| Operating Income (Reported) | -- | -$20M | -$25M | $8M | -$112M | |
| Operating Income (Adjusted) | -- | -$20M | -$19M | $8M | -$112M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $1.7B | $2B | $1.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $884M | $1B | $957M | |
| Gross Profit | -- | -- | $776M | $1B | $844M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $719M | $888M | $1B | |
| Selling, General & Admin | -- | -- | $162M | $197M | $188M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -$2.7B | |
| Operating Expenses | -- | -- | $881M | $1.1B | $1.2B | |
| Operating Income | -- | -- | -$105M | -$82M | -$371M | |
| Net Interest Expenses | -- | -- | $7M | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$112M | -$34M | -$3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $53M | $26M | -$55M | |
| Net Income to Company | -- | -- | -- | -$60M | -$3B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$165M | -$60M | -$3B | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.21 | -$0.08 | -$3.65 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.21 | -$0.08 | -$3.65 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | $482M | $455M | $184M | |
| EBIT | -- | -- | -$94M | -$68M | -$322M | |
| Revenue (Reported) | -- | -- | $1.7B | $2B | $1.8B | |
| Operating Income (Reported) | -- | -- | -$105M | -$82M | -$371M | |
| Operating Income (Adjusted) | -- | -- | -$94M | -$68M | -$322M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $326M | $1.3B | $1.4B | $1.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $173M | $682M | $739M | $664M | |
| Gross Profit | -- | $153M | $622M | $703M | $500M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $132M | $565M | $664M | $802M | |
| Selling, General & Admin | -- | $41M | $118M | $145M | $142M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -$2.7B | |
| Operating Expenses | -- | $173M | $683M | $809M | $944M | |
| Operating Income | -- | -$20M | -$61M | -$106M | -$444M | |
| Net Interest Expenses | -- | -- | $7M | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$20M | -$66M | -$68M | -$3.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $6M | $46M | $22M | -$76M | |
| Net Income to Company | -- | -- | -$112M | -$90M | -$3B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$26M | -$112M | -$90M | -$3B | |
| Basic EPS (Cont. Ops) | -- | -$0.03 | -$0.14 | -$0.12 | -$3.73 | |
| Diluted EPS (Cont. Ops) | -- | -$0.03 | -$0.14 | -$0.12 | -$3.73 | |
| Weighted Average Basic Share | -- | $795.8M | $2.4B | $2.4B | $2.4B | |
| Weighted Average Diluted Share | -- | $795.8M | $2.4B | $2.4B | $2.4B | |
| EBITDA | -- | $108M | $382M | $280M | -$65M | |
| EBIT | -- | -$20M | -$48M | -$106M | -$444M | |
| Revenue (Reported) | -- | $326M | $1.3B | $1.4B | $1.2B | |
| Operating Income (Reported) | -- | -$20M | -$61M | -$106M | -$444M | |
| Operating Income (Adjusted) | -- | -$20M | -$48M | -$106M | -$444M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $85M | $616M | $1B | $1.2B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | $93M | $155M | $269M | $357M | |
| Inventory | -- | $128M | $97M | $113M | $391M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | $54M | $76M | $110M | $106M | |
| Total Current Assets | -- | $1.7B | $2.3B | $1.5B | $2.1B | |
| Property Plant And Equipment | -- | $187M | $304M | $384M | $447M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | $10.9B | $10.9B | $10.9B | $10.9B | |
| Other Intangibles | -- | $3.6B | $3.1B | $2.5B | $2.1B | |
| Other Long-Term Assets | -- | $108M | $115M | $119M | $116M | |
| Total Assets | -- | $16.5B | $16.7B | $15.4B | $15.6B | |
| Accounts Payable | -- | $109M | $160M | $189M | $229M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | $27M | $49M | $34M | $48M | |
| Total Current Liabilities | -- | $310M | $474M | $384M | $403M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $620M | $766M | $647M | $653M | |
| Common Stock | -- | $15.8B | $15.9B | $9M | $8M | |
| Other Common Equity Adj | -- | -- | $5M | -$9M | -- | |
| Common Equity | -- | $15.8B | $15.9B | $14.8B | $14.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | $15.8B | $15.9B | $14.8B | $14.9B | |
| Total Liabilities and Equity | -- | $16.5B | $16.7B | $15.4B | $15.6B | |
| Cash and Short Terms | -- | $85M | $616M | $1B | $1.2B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $871M | $1.2B | $1.3B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | $222M | $281M | $223M | |
| Inventory | -- | -- | $105M | $354M | $457M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | $63M | $80M | $126M | |
| Total Current Assets | -- | -- | $2.2B | $1.9B | $2.1B | |
| Property Plant And Equipment | -- | -- | $354M | $426M | $461M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | $10.9B | $10.9B | $8.2B | |
| Other Intangibles | -- | -- | $2.7B | $2.2B | $1.7B | |
| Other Long-Term Assets | -- | -- | $95M | $111M | $123M | |
| Total Assets | -- | -- | $16.2B | $15.5B | $12.6B | |
| Accounts Payable | -- | -- | $160M | $221M | $166M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | $59M | $47M | $38M | |
| Total Current Liabilities | -- | -- | $4.8B | $391M | $362M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $5B | $632M | $525M | |
| Common Stock | -- | -- | $11.2B | $8M | $8M | |
| Other Common Equity Adj | -- | -- | -$18M | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $11.2B | $14.9B | $12.1B | |
| Total Liabilities and Equity | -- | -- | $16.2B | $15.5B | $12.6B | |
| Cash and Short Terms | -- | -- | $871M | $1.2B | $1.3B | |
| Total Debt | -- | -- | $3.5B | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$328M | -$196M | -$75M | -$82M | -$27M | |
| Depreciation & Amoritzation | $338M | $463M | $526M | $567M | $513M | |
| Stock-Based Compensation | $76M | $85M | $97M | $174M | $252M | |
| Change in Accounts Receivable | -$45M | $7M | -$62M | -$114M | -$88M | |
| Change in Inventories | -$26M | -$25M | $31M | -$16M | -$278M | |
| Cash From Operations | $300M | $271M | $599M | $546M | $394M | |
| Capital Expenditures | $44M | $91M | $143M | $111M | $98M | |
| Cash Acquisitions | -- | -$745M | -- | -- | -- | |
| Cash From Investing | -$225M | -$965M | -$157M | $1.2B | -$98M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$337M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$59M | $732M | $91M | -$2B | -$100M | |
| Cash From Financing | -$59M | $732M | $91M | -$1.3B | -$100M | |
| Beginning Cash (CF) | $39M | $55M | $93M | $625M | $1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $16M | $38M | $533M | $416M | $196M | |
| Ending Cash (CF) | $55M | $93M | $625M | $1B | $1.2B | |
| Levered Free Cash Flow | $256M | $180M | $456M | $435M | $296M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$45M | $17M | -$2.7B | |
| Depreciation & Amoritzation | -- | -- | $138M | $120M | $127M | |
| Stock-Based Compensation | -- | -- | $36M | $63M | $79M | |
| Change in Accounts Receivable | -- | -- | -$8M | -$23M | -$20M | |
| Change in Inventories | -- | -- | -$7M | -$91M | $28M | |
| Cash From Operations | -- | -- | $162M | $88M | $126M | |
| Capital Expenditures | -- | -- | $26M | $17M | $22M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$25M | -$17M | -$34M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$36M | -$17M | -$5M | |
| Cash From Financing | -- | -- | -$36M | -$17M | -$5M | |
| Beginning Cash (CF) | -- | -- | $784M | $1.2B | $1.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -$3M | -$4M | $3M | |
| Additions / Reductions | -- | -- | $101M | $54M | $87M | |
| Ending Cash (CF) | -- | -- | $882M | $1.2B | $1.3B | |
| Levered Free Cash Flow | -- | -- | $136M | $71M | $104M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$60M | -$3B | |
| Depreciation & Amoritzation | -- | -- | -- | $523M | $506M | |
| Stock-Based Compensation | -- | -- | $112M | $252M | $265M | |
| Change in Accounts Receivable | -- | -- | -- | -$41M | $19M | |
| Change in Inventories | -- | -- | -- | -$249M | -$103M | |
| Cash From Operations | -- | -- | -- | $436M | $305M | |
| Capital Expenditures | -- | -- | $79M | $107M | $91M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | $793M | -$121M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$336M | -$1M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$1.9B | -$87M | |
| Cash From Financing | -- | -- | -- | -$895M | -$87M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $334M | $97M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | $329M | $214M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$112M | -$90M | -$3B | |
| Depreciation & Amoritzation | -- | -- | $430M | $386M | $379M | |
| Stock-Based Compensation | -- | -- | $112M | $190M | $203M | |
| Change in Accounts Receivable | -- | -- | -$67M | $6M | $113M | |
| Change in Inventories | -- | -- | -$8M | -$241M | -$66M | |
| Cash From Operations | -- | -- | $395M | $285M | $196M | |
| Capital Expenditures | -- | -- | $79M | $75M | $68M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | $319M | -$75M | -$98M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$336M | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$115M | -$29M | -$16M | |
| Cash From Financing | -- | -- | -$451M | -$29M | -$16M | |
| Beginning Cash (CF) | -- | -- | $2.2B | $3.4B | $3.7B | |
| Foreign Exchange Rate Adjustment | -- | -- | -$6M | -$9M | -$2M | |
| Additions / Reductions | -- | -- | $263M | $181M | $82M | |
| Ending Cash (CF) | -- | -- | $2.4B | $3.5B | $3.8B | |
| Levered Free Cash Flow | -- | -- | $316M | $210M | $128M | |
Get MBLY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MBLY
Sector
P/E ratio
--
16.83x
PEG ratio
0.00x
0.22x
P/B ratio
1.18x
1.45x
Price / LTM sales
7.86x
0.71x
Growth Metrics
MBLY
Sector
Revenue growth
-8.3%
0.14%
Earnings growth
--
--
Revenue (5-year growth)
--
3.45%
Earnings forecast
$0.10
$0.30
Profitability
MBLY
Sector
Profitability FY 2023
$1B
$503.7M
Return on invested capital
-20.71%
5.17%
Return on assets
-19.88%
3.13%
Return on equity
-20.71%
7.63%
Earnings Date
Last Earnings Date
Oct
31
Next Earnings Date
Jan
24
Estimated Next Earnings Date
Jan
30
Balance Sheet
MBLY
Sector
Total cash
$1.3B
$157.7M
Short term investments
--
$60.7M
Total assets
$15.6B
$1.7B
Long term debt
--
$111.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
